- Genetic screening detects risk or affected embryos/foetuses; it is not automatically prevention.
- Genetic engineering aims to alter genetic information or gene expression.
- Current genetic prevention is strongest for specific known genetic risks.
- Evaluation must include effectiveness, limitations, ethics and access.
Year 12 Biology
Module 8 · IQ4
⏱ ~45 min
Practice bank · 3 Short Answer
Lesson 17 of 21
Prevention · diagnosis · genetics
Genetic Prevention: Screening and Engineering
Genetic technologies can sometimes prevent disease, reduce risk or guide early management. Learn the difference between screening, selection, treatment and true prevention.
Today's hook: If a genetic test finds high disease risk, has the disease been prevented, predicted or only detected?
0/5TASKS
Warm up first
Three quick questions from earlier lessons. Pulling old material back to mind before you learn something new makes the new material stick better, so this is not busywork.
Worksheets
Practise this lesson
Four printable worksheets that build from the foundations up to exam-style questions, start at whatever level suits you.
Lesson map
Detect -> reduce risk -> evaluate limits
Keep genetic technology tied to prevention, not a repeat of genetic-disease catalogues.
- 1Separate detection from prevention.Screening can guide action but does not itself change DNA.
- 2Explain the genetic option.Selection, monitoring, therapy and engineering have different roles.
- 3Evaluate the strategy.Judge effectiveness, ethics, access and current status.
Know what matters
- PGT can reduce the chance of some inherited diseases in IVF embryos.
- Gene therapy may treat disease without preventing inheritance.
- Multifactorial diseases are harder to prevent genetically.
- Somatic versus germline editing.
- CRISPR delivery, off-target risk and cost barriers.
- Ethical concerns including autonomy, equity and discrimination.
0
Predict first: prevented or detected?
connectA newborn screen detects PKU early, and the baby starts a low-phenylalanine diet before symptoms occur. What did the test do?
1
Key vocabulary, translated
vocabScreeningtesting to identify risk before symptoms
PGTtesting IVF embryos before implantation
Gene therapyadding, replacing or altering genes to treat disease
Genetic engineeringdeliberate change to genetic material or expression
Somatic editingediting body cells, not inherited by children
True or false: somatic gene therapy changes the patient's children as well.
2
What each genetic strategy can and cannot do
applyScreening
Finds risk early. Prevention depends on what action follows.
PGT
Can select embryos without a known inherited variant, but requires IVF and raises ethical questions.
Gene engineering
May correct or reduce a genetic problem in some contexts, but access, delivery and safety limit use.
Build an evaluation+7 XP
Put the genetic-prevention evaluation steps in order.
- Make a balanced judgement about prevention value.
- Identify the disease risk and genetic technology.
- State a limitation, ethical issue or access barrier.
- Explain how the technology reduces risk or guides action.
3
Current status matters
explainSome genetic technologies are established for detection or selection, while many engineering approaches remain limited to specific diseases or research contexts. Strong HSC answers avoid claiming CRISPR is a widespread prevention method for all genetic disease.
HSC exam move
Use cautious wording: "can reduce risk in specific cases" is usually more accurate than "prevents genetic disease". Then evaluate access, ethics and evidence.
4
Choose your route
differentiateClassify one technology as detection, selection, treatment or prevention.
Evaluate PGT as a prevention strategy for one inherited disease.
Evaluate the claim that gene editing will make genetic disease entirely preventable.
5
Exit check
retrieveMemorise
Screening, PGT, gene therapy, genetic engineering, somatic editing.
Understand
Detection is not the same as prevention; action after testing matters.
Apply
Evaluate one genetic prevention method using benefits and limits.
Avoid
Do not imply all genetic diseases can currently be prevented.
01
Multiple Choice
+5 XP
A fresh set drawn from this lesson's question bank, feedback shown immediately. +5 XP per correct · +25 XP all correct
Pick your answer, then rate your confidence, that tells the system what to drill next.
02
Short Answer, 15 marks
+5 XP
UnderstandBand 3–4(4 marks) 1. A newborn screening test detects phenylketonuria (PKU) before symptoms develop. Explain why the test is detection rather than genetic engineering, and how the action that follows can prevent symptoms without changing the child's DNA.
AnalyseBand 5(5 marks) 2. Compare the usefulness of NIPT (non-invasive prenatal testing) and amniocentesis as methods of detecting chromosomal abnormalities during pregnancy. Refer to: the type of test (screening vs diagnostic), procedural risk, timing, and information provided.
EvaluateBand 6(6 marks) 3. Evaluate the statement: "Advances in genetic technology mean that genetic disorders will soon be entirely preventable." Discuss gene therapy (including CRISPR), preimplantation genetic testing, and genetic screening programs. Consider both the scientific and ethical dimensions.
Show all answers
Multiple choice
MC answers and full explanations are shown inline as you complete each question. Use the retry button to attempt a fresh set from the lesson bank.
Worked examples: detection, selection and treatment
Newborn PKU screening: detection. It identifies risk early; dietary management then prevents toxic phenylalanine accumulation and neurological symptoms without editing DNA.
Preimplantation genetic testing: selection. Embryos created through IVF can be tested for a known familial variant before transfer. This can reduce transmission risk but does not alter an embryo's genes.
Somatic gene therapy: treatment. It changes selected body cells in the patient; it may reduce disease effects but is generally not inherited by the patient's children.
Worked example: evaluating genetic prevention
PGT can reduce the chance of transferring a known inherited variant, but it requires IVF, does not help with every de novo or multifactorial condition, and raises cost, access and embryo-selection questions. Somatic CRISPR may treat particular diseases, but delivery, off-target effects and cost limit its use, and changes to body cells do not prevent inheritance. A balanced judgement therefore distinguishes established screening or selection from emerging engineering and avoids claiming that all genetic disease is preventable.
Short Answer Model Answers
SA1 (4 marks): Newborn screening detects a biochemical pattern or risk associated with PKU; it does not insert, remove or edit the PAH gene, so it is detection rather than genetic engineering [2]. Early dietary management limits phenylalanine intake, preventing toxic accumulation and damage to the developing nervous system [1]. Symptoms can therefore be prevented even though the child's genotype remains unchanged [1].
SA2 (5 marks): NIPT, a screening test (identifies risk, doesn't diagnose); analyses cell-free fetal DNA in maternal blood; from 10 weeks; no procedural miscarriage risk; highly sensitive for trisomies 21/18/13 but a positive result needs confirmation; doesn't detect most single-gene/structural abnormalities [2]. Amniocentesis, a diagnostic test (definitive); fetal cells from amniotic fluid karyotyped or sequenced; at 15–20 weeks; ~0.5% miscarriage risk; detects chromosomal AND single-gene disorders; results in days–weeks [2]. Comparison: NIPT is used first (low-risk, early) to flag at-risk pregnancies; amniocentesis confirms a positive NIPT or is offered for older maternal age/family history, a trade-off between risk, certainty and timing [1].
SA3 (6 marks): Judgement: the statement is an oversimplification, genetic disorders will not be "entirely" preventable in the near future. Gene therapy/CRISPR (2 marks): Casgevy (2023, sickle-cell/β-thalassaemia) is a genuine breakthrough, but somatic editing does not prevent inheritance, germline editing is banned, delivery to many organs remains unsolved, and ~$3M cost limits access, so CRISPR is not a population-level prevention strategy. PGT and prenatal screening (2 marks): PGT selects unaffected IVF embryos (effective for known single-gene risk but needs IVF); NIPT/amniocentesis enable prenatal detection, but prevention then depends on termination decisions; access is inequitable globally. Scientific/ethical evaluation (2 marks): de novo chromosomal disorders cannot be prevented by gene therapy (require diagnosis/embryo selection); multifactorial disorders, most of the disease burden, are not addressable by single-gene approaches; ethical issues include reproductive autonomy, genetic discrimination, eugenics risk, and equity. Balanced conclusion: prevention is increasingly possible for specific single-gene disorders, but "entirely preventable" ignores multifactorial complexity, equity barriers and ethical limits.
Check what actually stuck
Take the full module quiz
quiz
A full module quiz covering every lesson in this module, not just this one. Set aside a decent block of time and treat it like a real assessment.
Start the module quiz →BOSS BATTLE · GENETIC PREVENTION
Screening and Engineering Final!
Use your knowledge of screening, PGT, gene therapy, CRISPR and ethical limits to defeat the boss. Pool: lessons 1–17.
REVISIT YOUR THINKING
Was the CRISPR claim accurate?
Return to the claim that genetic technology will make genetic disease entirely preventable. Use the lesson's central distinction: screening detects risk, PGT selects among embryos, and genetic engineering changes genetic material or expression. Each option has different benefits, limits and ethical implications.
- Detection: screening can identify risk or disease early, but prevention depends on what action follows.
- Selection and treatment: PGT may reduce transmission risk for a known familial variant, while somatic gene therapy treats a patient without usually changing inheritance.
- Limits: delivery, off-target effects, multifactorial disease, cost, access, autonomy and germline ethics prevent a simple claim that all genetic disease is preventable.